We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes(LADA) (DPP-ⅣLADA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01159847
Recruitment Status : Unknown
Verified January 2010 by European Foundation for the Study of Diabetes.
Recruitment status was:  Enrolling by invitation
First Posted : July 12, 2010
Last Update Posted : July 12, 2010
Chinese Medical Association
Eli Lilly and Company
Information provided by:
European Foundation for the Study of Diabetes

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2012
  Estimated Study Completion Date : December 2012